INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
10/30/2025
Back to search
Official data from USPTO
PASYLATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PASYLATION
ST13
US500000079126686Class
1, 5, 42
Filing
79126686
Registration
4483086
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
10/31/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/17/2012
Registration date
02/18/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2024
Last transaction
10/31/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Freising, DE
Examiner
BEVERLY,JOSETTE MICHELLE
Current location
Historical data usage
Holders and representatives
Holders
XL-protein GmbH
XL-protein GmbH
Representatives
Anthony G. Craig Sci-Law Strategies, PC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposesfor industrial and scientific purposes; unprocessed artificial resinsunprocessed plastics; chemical and biological preparations for medical research and medical and scientific purposes
Class 5
Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; sanitary preparations for medical purposes; dietetic substances adapted for medical usenutritional supplements containing proteinspeptidesfood for babies; preparations for destroying vermin; fungicidesherbicides; pharmaceutical and diagnostic preparations for medicaldental and forensic purposes and for purposes of forensic medicine and laboratory medicinepharmaceutical and diagnostic preparations for diagnosispreventiontreatment or cure of growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; testing reagents in kit form for medicaldental and forensic purposes and for purposes of forensic medicine and laboratory medicinemedical and forensic diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposesreagents and solvents for sample preparationmodification and manipulation of cells and for performing of markingseparationisolationpurificationamplification and/or analytical methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventivecurative and palliative purposes for preventingtreating or curing of growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; medical biomarkersin particular for preventativediagnosticprognostic or predictive purposespolypeptide sequences; medical preparationskits for laboratory medicine in particular for preventivediagnosticprognostic or predictive purposesdiagnostic kits consisting primarily of proteinsbuffersreagents for use in detecting growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; biomolecules for medical purposesproteinspeptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposesreagents for detecting growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases; preparations for health carefor diagnosispreventiontreatmentcure of growth deficienciesinflammationinfectionsobesitydiabetesmalignanciesmetabolic diseasescancercardiovascular diseasesdiseases of the CNSeye diseasesbone diseases
Class 42
Scientific and technological services and researchscientific researchanalysistestingin the fields of chemistrygeneticsbiologybiotechnology and biochemistry; technical servicescomputer diagnostic services in the field of DNARNA and protein expressiondetection and analysis and respective design servicesin particular in the fields of chemistrygeneticsbiologybiotechnology and biochemistry; industrial analysis and research services in the field of medicaldentalforensic and scientific research; design and development of computer hardware and software; services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checkingquality evaluation services for the medical and pharmaceutical industry; design and development of programs for data processing; consultancy for scientificlaboratory and research purposes in the field of chemistrygeneticsbiologybiotechnology and biochemistry; scientific services of a technical measuring and test laboratory; technological consulting services pertaining to scientific and industrial scientific research in the fields of generationtechnical processing and technical analysis of biomaterials and medically relevant data
Publications
History of USPTO decisions and trademark events.
56 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/08/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/07/2024
71AG
REGISTERED-SEC.71 ACCEPTED
10/07/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/07/2024
ES71
TEAS SECTION 71 RECEIVED
02/12/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/18/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/04/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/02/2022
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
09/09/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/29/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
02/13/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/01/2021
INPC
INVALIDATION PROCESSED
12/31/2020
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/29/2020
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/29/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/27/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/02/2020
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
05/12/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2020
ES75
TEAS SECTION 71 & 15 RECEIVED
02/18/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/18/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/18/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/18/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/18/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/18/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/18/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/13/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/27/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/06/2014
FIMP
FINAL DISPOSITION PROCESSED
06/06/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/18/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2013
PUBO
PUBLISHED FOR OPPOSITION
12/03/2013
GPNX
NOTIFICATION PROCESSED BY IB
12/02/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/13/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/13/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/30/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/29/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2013
ALIE
ASSIGNED TO LIE
09/20/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/19/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/19/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2013
RFNT
REFUSAL PROCESSED BY IB
04/23/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/28/2013
RFRR
REFUSAL PROCESSED BY MPU
03/28/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/28/2013
CNRT
NON-FINAL ACTION WRITTEN
03/27/2013
MAFR
APPLICATION FILING RECEIPT MAILED
03/22/2013
DOCK
ASSIGNED TO EXAMINER
03/18/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/15/2013
Continuous trademark protection
Get notified about every new filing that threatens PASYLATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.